Benjamin Burnett
Stock Analyst at Wells Fargo
(0.95)
# 3,949
Out of 4,988 analysts
433
Total ratings
40.7%
Success rate
-1%
Average return
Main Sectors:
Stocks Rated by Benjamin Burnett
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| RARE Ultragenyx Pharmaceutical | Rated: Hold | $18 | $14.51 | +24.05% | 12 | Sep 18, 2026 | |
| XENE Xenon Pharmaceuticals | Reiterated: Buy | $69 → $64 | $39.75 | +61.01% | 13 | Sep 18, 2026 | |
| AXSM Axsome Therapeutics | Reiterated: Buy | $256 | $207.78 | +23.21% | 10 | Sep 10, 2026 | |
| WVE Wave Life Sciences | Reiterated: Buy | $14 | $4.35 | +221.84% | 10 | Sep 9, 2026 | |
| LQDA Liquidia | Reiterated: Buy | $108 | $66.88 | +61.48% | 10 | Sep 8, 2026 | |
| AMPH Amphastar Pharmaceuticals | Reiterated: Hold | $20 | $23.62 | -15.33% | 3 | Sep 2, 2026 | |
| KROS Keros Therapeutics | Reiterated: Buy | $18 | $11.19 | +60.86% | 6 | Sep 2, 2026 | |
| MNKD MannKind | Reiterated: Buy | $13 | $3.54 | +267.23% | 9 | Sep 2, 2026 | |
| PTCT PTC Therapeutics | Reiterated: Buy | $109 | $65.37 | +66.74% | 9 | Sep 2, 2026 | |
| UTHR United Therapeutics | Reiterated: Buy | $700 | $494.63 | +41.52% | 12 | Sep 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $13 | $15.19 | -14.42% | 3 | Aug 31, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $72 | $38.81 | +85.52% | 3 | Aug 31, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $44 | $28.26 | +55.70% | 2 | Aug 31, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $9 | $5.37 | +67.60% | 6 | Aug 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $323 → $362 | $298.95 | +21.09% | 7 | Aug 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $101 → $93 | $27.00 | +244.44% | 4 | Aug 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $161 → $169 | $120.00 | +40.83% | 9 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $65 | $43.39 | +49.80% | 12 | Jul 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $46 | $40.45 | +13.72% | 3 | Apr 22, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $78 → $64 | $190.95 | n/a | 19 | Apr 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $26 → $13 | $2.55 | n/a | 8 | Mar 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $7 | $7.78 | n/a | 19 | Mar 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $4.5 → $4 | $1.69 | n/a | 23 | Mar 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $18 | $10.25 | n/a | 33 | Mar 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $5 → $3 | $9.69 | n/a | 30 | Mar 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $5 → $3 | $2.53 | n/a | 23 | Mar 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $94 → $92 | $69.53 | n/a | 21 | Mar 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $80 | $0.6178 | n/a | 7 | Mar 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $53 → $49 | $56.56 | n/a | 23 | Feb 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $66 → $64 | $38.41 | n/a | 20 | Nov 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $10 | $0.0002 | n/a | 15 | Apr 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $42 | $6.67 | n/a | 11 | Aug 16, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $3.9 → $3.6 | $0.1449 | n/a | 12 | Aug 10, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $4.7 → $3 | $67.10 | n/a | 12 | Mar 2, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $4.5 | $32.09 | n/a | 3 | Nov 15, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $4.7 → $0.16 | $0.0001 | n/a | 9 | Apr 29, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $84 → $120 | $24.95 | n/a | 2 | Feb 28, 2022 |
Ultragenyx Pharmaceutical
Sep 18, 2026
Rated: Hold
Price Target: $18
Current: $14.51
Upside: +24.05%
Xenon Pharmaceuticals
Sep 18, 2026
Reiterated: Buy
Price Target: $69 → $64
Current: $39.75
Upside: +61.01%
Axsome Therapeutics
Sep 10, 2026
Reiterated: Buy
Price Target: $256
Current: $207.78
Upside: +23.21%
Wave Life Sciences
Sep 9, 2026
Reiterated: Buy
Price Target: $14
Current: $4.35
Upside: +221.84%
Liquidia
Sep 8, 2026
Reiterated: Buy
Price Target: $108
Current: $66.88
Upside: +61.48%
Amphastar Pharmaceuticals
Sep 2, 2026
Reiterated: Hold
Price Target: $20
Current: $23.62
Upside: -15.33%
Keros Therapeutics
Sep 2, 2026
Reiterated: Buy
Price Target: $18
Current: $11.19
Upside: +60.86%
MannKind
Sep 2, 2026
Reiterated: Buy
Price Target: $13
Current: $3.54
Upside: +267.23%
PTC Therapeutics
Sep 2, 2026
Reiterated: Buy
Price Target: $109
Current: $65.37
Upside: +66.74%
United Therapeutics
Sep 2, 2026
Reiterated: Buy
Price Target: $700
Current: $494.63
Upside: +41.52%
Aug 31, 2026
Reiterated: Hold
Price Target: $13
Current: $15.19
Upside: -14.42%
Aug 31, 2026
Reiterated: Buy
Price Target: $72
Current: $38.81
Upside: +85.52%
Aug 31, 2026
Reiterated: Buy
Price Target: $44
Current: $28.26
Upside: +55.70%
Aug 11, 2026
Rated: Buy
Price Target: $9
Current: $5.37
Upside: +67.60%
Aug 7, 2026
Reiterated: Hold
Price Target: $323 → $362
Current: $298.95
Upside: +21.09%
Aug 7, 2026
Reiterated: Buy
Price Target: $101 → $93
Current: $27.00
Upside: +244.44%
Aug 6, 2026
Reiterated: Buy
Price Target: $161 → $169
Current: $120.00
Upside: +40.83%
Jul 29, 2026
Rated: Buy
Price Target: $65
Current: $43.39
Upside: +49.80%
Apr 22, 2026
Reiterated: Buy
Price Target: $46
Current: $40.45
Upside: +13.72%
Apr 1, 2025
Reiterated: Buy
Price Target: $78 → $64
Current: $190.95
Upside: n/a
Mar 31, 2025
Reiterated: Buy
Price Target: $26 → $13
Current: $2.55
Upside: n/a
Mar 20, 2025
Reiterated: Buy
Price Target: $7
Current: $7.78
Upside: n/a
Mar 17, 2025
Reiterated: Hold
Price Target: $4.5 → $4
Current: $1.69
Upside: n/a
Mar 17, 2025
Reiterated: Buy
Price Target: $18
Current: $10.25
Upside: n/a
Mar 11, 2025
Reiterated: Hold
Price Target: $5 → $3
Current: $9.69
Upside: n/a
Mar 6, 2025
Reiterated: Hold
Price Target: $5 → $3
Current: $2.53
Upside: n/a
Mar 3, 2025
Reiterated: Buy
Price Target: $94 → $92
Current: $69.53
Upside: n/a
Mar 2, 2025
Reiterated: Buy
Price Target: $80
Current: $0.6178
Upside: n/a
Feb 13, 2025
Reiterated: Hold
Price Target: $53 → $49
Current: $56.56
Upside: n/a
Nov 6, 2024
Reiterated: Buy
Price Target: $66 → $64
Current: $38.41
Upside: n/a
Apr 19, 2024
Reiterated: Buy
Price Target: $10
Current: $0.0002
Upside: n/a
Aug 16, 2023
Reiterated: Buy
Price Target: $42
Current: $6.67
Upside: n/a
Aug 10, 2023
Reiterated: Hold
Price Target: $3.9 → $3.6
Current: $0.1449
Upside: n/a
Mar 2, 2023
Reiterated: Hold
Price Target: $4.7 → $3
Current: $67.10
Upside: n/a
Nov 15, 2022
Downgraded: Hold
Price Target: $4.5
Current: $32.09
Upside: n/a
Apr 29, 2022
Downgraded: Hold
Price Target: $4.7 → $0.16
Current: $0.0001
Upside: n/a
Feb 28, 2022
Reiterated: Buy
Price Target: $84 → $120
Current: $24.95
Upside: n/a